What is the fair value of Escalon Medical Corp (OTC-ESMC) stock?

The current fair value estimate for Escalon Medical Corp (OTC-ESMC) is $0.21. This implies an estimated upside of 35.4% versus the current market price.

Is Escalon Medical Corp (OTC-ESMC) undervalued or overvalued?

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 35.4% versus the current market price.

How is the financial health of Escalon Medical Corp?

The current financial health read for Escalon Medical Corp (OTC-ESMC) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

When is Escalon Medical Corp's next earnings date?

The next earnings date currently listed for Escalon Medical Corp (OTC-ESMC) is September 28, 2026.

Does Escalon Medical Corp (OTC-ESMC) pay dividends?

The latest available data indicates no current dividend yield for Escalon Medical Corp (OTC-ESMC).

What is the P/E ratio for Escalon Medical Corp (OTC-ESMC)?

The current P/E ratio listed for Escalon Medical Corp (OTC-ESMC) is 1.3x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

What is the market capitalization of Escalon Medical Corp?

The current market capitalization listed for Escalon Medical Corp is 1.149 M.

What is the enterprise value of Escalon Medical Corp?

The current enterprise value listed for Escalon Medical Corp is -537.584 K. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

What is the ticker symbol for Escalon Medical Corp?

The ticker symbol for Escalon Medical Corp is OTC-ESMC, and the stock is listed on OTC Markets.

Where is Escalon Medical Corp (OTC-ESMC) listed?

Escalon Medical Corp (OTC-ESMC) is listed on OTC Markets.

What is the debt-to-total-capital ratio for Escalon Medical Corp?

The current debt-to-total-capital ratio listed for Escalon Medical Corp is 36.0%, which helps investors evaluate the company’s financing structure and leverage profile.

What is the free float for Escalon Medical Corp?

The free float listed for Escalon Medical Corp is 98.1%. Free float helps investors understand how much of the share base is available for public trading.

Escalon Medical Corp (ESMC) Fair Value & Stock Analysis

Escalon Medical Corp (ESMC)

Escalon Medical Corp is a common stock listing on OTC Markets. The company develops, manufactures, markets, and distributes medical devices and pharmaceuticals focused on ophthalmic applications in the United States and abroad. Its product portfolio includes diagnostic tools such as A-Scan, B-Scan, UBM, and Pachymeter, along with Ispan Intraocular Gases used in vitreoretinal procedures. Escalon also provides the AXIS image management system for ophthalmic diagnostic images and disposable surgical packs used in vitreoretinal surgery, including products designed to assist with silicone oil injection and extraction. In addition, it manufactures and distributes a patented disposable universal gas kit. The company sells through independent sales representatives, distributors, and internal sales personnel. Escalon Medical Corp was incorporated in 1987 and is based in Wayne, Pennsylvania.

Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.

Ticker	Fair Value	Fair Value Upside/Downside	Fair Value Rating	Analyst Price Target	Analyst Target Upside/Downside	Overall Financial Health	Dividend Yield	Next Earnings Date	P/E Ratio	Price-to-Book Ratio	Price-to-Sales Ratio	Market Cap	Enterprise Value	Total Debt / Total Capital	Free Float / Shares Outstanding	Altman Z-Score	Free Cash Flow / Net Income
OTC-ESMC	$0.21	35.4% Upside	Undervalued	Not available	Not available	Good	0.0%	September 28, 2026	1.3x	0.3x	0.1x	1.149 M	-537.584 K	36.0%	98.1%	-21.4	-15.7%